发明名称 Fremgangsmåde til fremstilling af benzofuranderivater eller salte heraf.
摘要 <p>1,084,290. Benzofurans. HASSLE, APOTEKARE PAUL NORDSTROMS FABRIKER A.B. Dec. 2, 1964 [Dec. 2, 1963], No. 49068/64. Heading C2C. New compounds of Formula (I) wherein m and n are each 1 or 2, R is lower (i.e. up to 5C) alkyl, lower alkoxystyryl or a phenyl group optionally substituted by lower alkyl, lower alkoxy, lower alkylene dioxy, fluorine, chlorine, bromine or trifluoromethyl, R<SP>1</SP> is (when n is 1) hydrogen, fluorine, chlorine, bromine, lower alkyl or lower alkoxy or together with R<SP>2</SP> represents benzo, R<SP>2</SP> is (when m is 1) hydrogen, fluorine, chlorine, bromine, benzoyl, lower alkyl or lower alkoxy, or (when R<SP>1</SP> is hydrogen) nitro, amino, hydroxy, lower acyloxy, lower alkoxybenzoyloxy, lower dialkylamino or lower acylamino and, when n is 2, R<SP>1</SP> is methyl and, when m is 2, R<SP>2</SP> is chlorine, A is C 1-4 alkylene, R<SP>3</SP> is hydrogen or lower alkyl, R<SP>4</SP> is lower alkyl, #-phenylethyl or benzyl, or NR<SP>3</SP>R<SP>4</SP> is pyrrolidino, piperidino, hexamethyleneimino, morpholino, lower dialkylmorpholino, piperazino, lower alkylpiperazino, benzylpiperazino or tetrahydropyridino, and their pharmaceutically acceptable acid addition salts, are prepared by condensing a compound of Formula (II) with a compound Y-A<SP>1</SP>-NQ<SP>3</SP>Q<SP>4</SP> (wherein A<SP>1</SP>, Q, Q<SP>1</SP> and Q<SP>2</SP> correspond to A, R, R<SP>1</SP> and R<SP>2</SP> respectively save that hydroxy and amino groups Q<SP>2</SP> are substituted by protecting groups replaceable by hydrogen by hydrolysis or hydrogenation, Q<SP>3</SP> is lower alkyl or a said protecting group, Q<SP>4</SP> is as R<SP>4</SP>, NQ<SP>3</SP>Q<SP>4</SP> is as NR<SP>3</SP>R<SP>4</SP> save for the piperazino groups which are substituted in the 4-position by lower alkyl, benzyl or a said protecting group, and X and Y are atoms or groups reactable together to form an ether linkage), and where necessary replacing a said protecting group, optionally followed by acylation of amino or hydroxy groups R<SP>2</SP>, the optional hydrogenation of nitro to amino groups R<SP>2</SP> also being described. Starting materials which are 2-(R.CO)-3- HO-(R<SP>1</SP>) n (R<SP>2</SP>)m-benzofurans are preparable by methods (A) forming o-(R.COO)-chloracetophenones by acylation and treating these with NaH, (B) forming o-(R.COO)-acetophenones by acylation, bromination to o-(R.COO)- bromoacetophenones which are ring closed with NaOiPr, (C) treating o-(R.COO)-acetophenones with K 2 CO 3 to form o-(R.CO.CH 2 CO)- phenols which are ring closed with Br 2 /K 2 CO 3 . Additionally, 2 - (p - ethoxybenzoyl) - 3 - hydroxy - 6 - p - ethoxybenzoyloxy benzofuran is prepared from p-EtOPhCOCl and 2,4- diHO- #-chloroacetophenone. Pharmaceutical compositions comprise the new compounds with carriers, oral, rectal and parenteral preparations having analgesic, antipyretic, antiinflammatory, antitussive, anµsthetic and antispasmodic properties being described.</p>
申请公布号 DK109989(C) 申请公布日期 1968.08.19
申请号 DK19640005911 申请日期 1964.12.01
申请人 AKTIEBOLAGET HAESSLE, APOTEKARE PAUL NORDSTROEMS FABRIKER 发明人
分类号 C07D307/83;C07D405/12;(IPC1-7):C07D5/40 主分类号 C07D307/83
代理机构 代理人
主权项
地址